Dr Imen Hammami
Contact information
Imen Hammami
PhD, Diplôme d'Ingénieur
Senior Statistician
Imen Hammami is a Senior Statistician within the Hopewell Group. She joined Oxford Population Health in 2015 after completing a PhD in Biostatistics at Université René Descartes (Paris V) and an engineering degree (Diplôme d'Ingénieur) in Statistics and Data Analysis in Tunisia. Her research focuses on advanced statistical and multi-modal approaches, integrating large-scale omics and health data to strengthen disease understanding and patient profiling.
Imen is deeply engaged in teaching. She lectures in Statistics on the MSc in Global Health Science and Epidemiology, where she also leads the Data Science module, and serves on the Examination Board for the Clinical Trials MSc. She has co-designed and delivered short courses in Statistics, was a finalist (Highly Commended) in the Vice-Chancellor’s Award for Innovative Teaching and Assessment (2024), and received the Medical Sciences Division Teaching Excellence Award (2021, Education Project).
She is an active member of the Oxford Population Health community, including through the Race Self-Assessment Team, and continues to champion rigorous, engineering-driven methodology in research, training and practice at the interface of statistics, omics and population health.
Recent publications
Balancing the risk of major bleeding against vascular disease risk in people without atherosclerotic disease.
Journal article
Hammami I. et al, (2025), Heart, 111, 716 - 721
Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes.
Journal article
Sammons E. et al, (2025), BMJ Open, 15
Reproducibility and associated regression dilution bias of accelerometer-derived physical activity and sleep in the UK Biobank
Preprint
Zisou C. et al, (2025)
Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial.
Journal article
Sammons EL. et al, (2024), BMC Ophthalmol, 24
ASCEND-Eye: Effects of Aspirin on Diabetic Retinopathy.
Journal article
Sammons EL. et al, (2024), Ophthalmology, 131, 771 - 779
